Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

US Patent 6673775 · Granted Jan 6, 2004

Estimated economic value: $182,749,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic di-nucleotide compounds as sting agonists2023
Metallo-beta-lactamase inhibitors2020
Metallo-β-lactamase inhibitors2019
Metallo-beta-lactamase inhibitors2019
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof2017
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017
Substituted pyridine and pyrimidine derivatives and their use in treating viral 2016
2′-azido substituted nucleoside derivatives and methods of use thereof for the t2015
2′-cyano substituted nucleoside derivatives and methods of use thereof useful fo2015
2′-substituted nucleoside derivatives and methods of use thereof for the treatme2015
Topical administrations of antisense compounds to VLA-4 for the treatment of res2014
Substituted pyridine and pyrimidine derivatives and their use in treating viral 2014